Gene · 2175
Papers3,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,961 to 1,980 of 3,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A toxicogenomic approach for the risk assessment of the food contaminant acetamide. | Toxicol Appl Pharmacol | 2020 | 31881176 | PubTator, text mining | PubMed |
| Dynamic changes in intron retention are tightly associated with regulation of splicing factors and proliferative activity during B-cell development. | Nucleic Acids Res | 2020 | 31879760 | PubTator, text mining | PubMed |
| Microphthalmia transcription factor expression contributes to bone marrow failure in Fanconi anemia. | J Clin Invest | 2020 | 31877112 | PubTator, text mining | PubMed |
| NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers. | Mol Oncol | 2020 | 31854063 | PubTator, text mining | PubMed |
| Dihydropyrimidinase protects from DNA replication stress caused by cytotoxic metabolites. | Nucleic Acids Res | 2020 | 31853544 | PubTator, text mining | PubMed |
| 6mer Seed Toxicity in Viral microRNAs. | iScience | 2020 | 31838022 | PubTator, text mining | PubMed |
| Prostate cancer research: The next generation; report from the 2019 Coffey-Holden Prostate Cancer Academy Meeting. | Prostate | 2020 | 31825540 | PubTator, text mining | PubMed |
| Hsp90 and complex birth defects: A plausible mechanism for the interaction of genes and environment. | Neurosci Lett | 2020 | 31821846 | PubTator, text mining | PubMed |
| Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial. | Lancet Oncol | 2020 | 31806540 | PubTator, text mining | PubMed |
| Mouse models in hematopoietic stem cell gene therapy and genome editing. | Biochem Pharmacol | 2020 | 31705854 | PubTator, text mining | PubMed |
| RAD6B is a major mediator of triple negative breast cancer cisplatin resistance: Regulation of translesion synthesis/Fanconi anemia crosstalk and BRCA1 independence. | Biochim Biophys Acta Mol Basis Dis | 2020 | 31639439 | PubTator, text mining | PubMed |
| Genomic Profiling Identifies Association of IDH1/IDH2 Mutation with Longer Relapse-Free and Metastasis-Free Survival in High-Grade Chondrosarcoma. | Clin Cancer Res | 2020 | 31615936 | PubTator, text mining | PubMed |
| Neonicotinoid trapping by the FA1 site of human serum albumin. | IUBMB Life | 2020 | 31614076 | PubTator, text mining | PubMed |
| Optimised molecular genetic diagnostics of Fanconi anaemia by whole exome sequencing and functional studies. | J Med Genet | 2020 | 31586946 | PubTator, text mining | PubMed |
| Characterization and genotype-phenotype correlation of patients with Fanconi anemia in a multi-ethnic population. | Haematologica | 2020 | 31558676 | PubTator, text mining | PubMed |
| A founder variant in the South Asian population leads to a high prevalence of FANCL Fanconi anemia cases in India. | Hum Mutat | 2020 | 31513304 | PubTator, text mining | PubMed |
| DNA repair and cancer in colon and rectum: Novel players in genetic susceptibility. | Int J Cancer | 2020 | 31209889 | PubTator, text mining | PubMed |
| Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate Cancer. | Eur Urol | 2020 | 31176623 | PubTator, text mining | PubMed |
| Psychometric properties of the Cognitive and Behavioural Responses Questionnaire (CBRQ) in adolescents with chronic fatigue syndrome. | Behav Cogn Psychother | 2020 | 31113527 | PubTator, text mining | PubMed |
| DNA repair fidelity in stem cell maintenance, health, and disease. | Biochim Biophys Acta Mol Basis Dis | 2020 | 30953688 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2175/papers?page=99